Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-20-064849

Chief Financial Officer sold 141,110 shares at an average $1.62 ($228,179)

  • Chief Financial Officer acquired 141,110 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-18 Exercise or conversion : show line 1 in the form +53,610 $1.00 $53,610 403,220 D
2020-12-18 Sale : show line 2 in the form −53,610 $1.40 $75,054 349,610 D
2020-12-21 Exercise or conversion : show line 3 in the form +87,500 $1.40 $122,500 437,110 D
2020-12-21 Sale : show line 4 in the form −87,500 $1.75 $153,125 349,610 D
Open-market sales · 141,110 sh · avg $1.62 · $228,179

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2020-12-18 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −53,610 $1.00 $53,610 $1.00 2024-04-11 53,610 53,610 D
2020-12-21 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −87,500 $1.40 $122,500 $1.40 2026-01-07 87,500 87,500 D
Loading xslF345X03/doc4.xml…